Immediate Impact

63 standout
Sub-graph 1 of 20

Citing Papers

Phase 3 Trial of Semaglutide in Metabolic Dysfunction–Associated Steatohepatitis
2025 Standout
Changing etiology and epidemiology of hepatocellular carcinoma: Asia and worldwide
2024 Standout
1 intermediate paper

Works of Mani Subramanian being referenced

Improvement of hepatic fibrosis and patient‐reported outcomes in non‐alcoholic steatohepatitis treated with selonsertib
2018

Author Peers

Author Last Decade Papers Cites
Mani Subramanian 741 763 76 206 60 1.1k
T Maekawa 669 613 159 280 72 1.3k
Gerald Eder 687 672 143 248 38 1.4k
Eric G. Meissner 654 612 283 208 66 1.3k
Hacène Khiri 723 936 40 180 62 1.3k
Eiji Kajiwara 752 725 101 86 67 1.2k
Nasser Semmo 811 655 295 108 59 1.2k
C. Bréchot 855 912 68 220 54 1.2k
Olga Kalinina 466 440 108 282 58 1.2k
Samir Ali 483 378 86 216 34 890
Jane Fang 741 716 92 280 34 1.3k

All Works

Loading papers...

Rankless by CCL
2026